Pharmaceutical

Young, African-American dialysis patients at greater risk of dying

dialysis Young, African American dialysis patients at greater risk of dyingYoung African-Americans on dialysis are 1.5 times more likely to die than white dialysis patients, according to a study published in the Journal of the American Society of Nephrology.

The study, involving more than 11,000 patients, found the young African-American kidney patients most at risk of dying were those living in poorer neighborhoods. Part of the problem was diet and genetics.

However, young dialysis patients in general – specifically those between the ages of 18 and 30 – tend to feel more invincible, said researcher Dr. Tanya Johns. “We do find a lot of the young adults tend to do what we call ‘crash’ into dialysis rather than being prepared for it, which is associated with better survival.

Dialysis is a serious commitment. For 21-year-old Samantha Jones, it takes committing nearly four hours three times a week. She must abide by that schedule religiously or risk serious problems. That’s where the challenges come into play. Samantha wants to travel. And, she says, her social life is essentially “not existent.”

Dialysis patients – regardless of age – are also at greater risk of death than the general population. Complications and infections can be life threatening.

Fresenius Medical Care, the world’s largest provider of dialysis products and services, is currently facing hundreds of wrongful death lawsuits alleging the company tried to cover up information that its dialysis concentrates GranuFlo and NaturaLyte were labeled confusingly and that doctors could inadvertently prescribe patients doses containing lethal amounts of a substances that can trigger cardiovascular problems including sudden cardiac arrest.

Source: TWC News